Career Opportunities

Mucosis B.V. is an exciting, young Groningen-based Dutch biotech company developing innovative mucosal vaccines that are applied needle-free via the nose or mouth. Mucosis’s lead product candidates are FluGEM®, an intranasal vaccine to prevent influenza, SynGEM®, a vaccine to prevent respiratory syncytial virus infections and PneuGEM®, a vaccine to prevent pneumonia and mid ear infections. Our vaccines are based on Mimopath™, a unique technology that enables a robust natural immune response as well as a broad base of protection.

Mucosis is searching for team players with relevant experience in biotech industry who share our passion for excellence. We are currently recruiting for the positions outlined below. If you are interested in joining our team, please submit a resume and cover letter to  info@mucosis.com.

Job Listings

There are currently no vacancies

 

10.11.14 Mucosis Presents Data on Intranasal Respiratory Syncytial Virus Vaccine SynGEM® at RSV2014 Symposium
more >

20.10.14 Mucosis Presents Data on Intranasal RSV Vaccine SynGEM® at Vaccines 2014 Conference
more >

30.09.14 Mucosis Presents Infectious Diseases Vaccines Pipeline Update at SACHs Associates 14th Annual Biotech in Europe Forum
more >

22.05.14 Mucosis receives financial support from the Dutch government for its SynGEM® program
more >

15.04.14 Mucosis announces a strategic partnership with Changchun BCHT Biotechnology of China and raises additional capital
more >

12.08.13 Mucosis announces publication of data demonstrating safety and protection by mucosally administered Mimopath®-based prefusion-like F RSV vaccines
more >